Some studies in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) report CCL27 downregulation via Fas and epidermal growth factor receptor (EGFR) signaling to evade immunity (103). Here, CCL27 is linked to skin basal cell carcinoma.